• SENSEX 80,999.40
    -28.62 (--0.04%)
  • BANKNIFTY 58,850.65
    -235.35 (--0.40%)
  • NSE
    1,941.95 1,953.95(%)
  • Finolex Cables
    1,309.90 1,498.35(%)
  • Tonbo Imaging
    1,529.90 1,644.50(%)
  • HDFC Bank
    783.20 668.90(%)
  • Divi's Lab.
    11,195.95 10,305.00(%)
  • Jio Platforms
    1,426.00 1,490.00(%)
  • Banco Products
    698.85 865.45(%)
  • Reliance Industries
    1,324.90 1,611.20(%)
  • R R Kabel
    2,147.75 2,980.00(%)
  • N S D L
    786.90 1,180.00(%)
  • TD Power Systems
    614.75 856.00(%)
  • SBI
    1,014.25 933.85(%)
  • ICICI Bank
    1,563.40 1,187.55(%)
  • Tata Steel
    192.05 224.40(%)
  • Sterlite Tech.
    683.20 84.65(%)
  • Multi Comm. Exc.
    3,603.80 3,552.00(%)
  • Larsen & Toubro
    4,095.25 3,288.65(%)
  • M & M
    3,264.00 2,743.15(%)
  • Data Pattern
    3,590.00 2,131.00(%)
  • Acutaas Chemical
    3,960.00 4,040.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Source Natural Foods & Herbal Supplements Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 13792.0
  • ISIN : INE679C01027
113.95 6 (5.56%)
  • As on 08 Nov 2026 (EOD)

  • Today’s Low

    113.95

  • Today’s High

    125.00

  • Open

    125.00

  • Perv Close

    107.95

  • 52W Low

    96.55

  • 52W High

    155.90

Key Indicators

  • P/E(TTM)

    20.91

  • Mar.Cap (₹Cr.)

    73.35

  • Div & Yield %

    0.00

  • Book Value(₹)

    40.01

  • Debt-Equity Ratio

    5.56

  • AGM Date

    08-Nov-2026

  • EPS

    5.45

  • P/E Ratio

    20.91

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    73.35

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    6.44

  • BV (₹)

    40.00

  • Sales( ₹ in Cr.)

    70.38

  • NP (in Cr.)

    3.40

  • NP Var(%)

    17.0

  • Div%

    0.0

  • CPS (₹)

    5.90

  • EPS (₹)

    5.30

  • Traded Value (₹ in Lakhs)

    69.49

  • 52 Week High

    155.90

  • 52 Week Low

    96.55

  • Price BSE

    108.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    69.49

  • P/C Ratio

    18.40

  • P/E Ratio

    20.50

  • Price Vs.BV

    5.30

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 70.38 44.92 27.30 19.79 21.53 24.88
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 70.38 44.92 27.30 19.79 21.53 24.88
Other Income 0.06 0.08 0.01 0.01 0.49 0.34
Stock Adjustments 0.17 1.09 1.39 0.40 0.62 -0.07
Total Income 70.61 46.09 28.70 20.20 22.64 25.15
EXPENDITURE :            
Raw Materials 55.37 34.56 18.16 10.25 10.05 9.84
Power and Fuel Cost 0.43 0.28 0.30 0.28 0.32 0.33
Employee Cost 4.47 3.27 2.88 3.14 3.86 2.54
Other Manufacturing Expenses 0.28 0.22 1.60 1.35 1.98 2.12
Selling and Administration Expenses 3.41 2.54 1.27 1.56 1.86 4.86
Miscellaneous Expenses 0.67 0.66 0.05 0.00 0.22 0.94
Employee Benefit Expenses 4.47 3.27 2.88 3.14 3.86 2.54
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 64.64 41.53 24.26 16.57 18.30 20.64
Operating Profit 5.96 4.56 4.43 3.62 4.34 4.50
Interest 0.66 0.62 0.21 0.27 0.24 0.10
Gross Profit 5.30 3.94 4.22 3.35 4.10 4.40
Depreciation 0.38 0.36 1.04 0.62 0.42 0.37
Profit Before Tax 4.92 3.58 3.18 2.73 3.68 4.03
Current Tax 1.52 0.68 1.12 0.61 0.91 1.32
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.32 0.01 0.34 -0.66
Reported Net Profit 3.40 2.90 1.74 2.12 2.43 3.37
Extraordinary Items 0.00 0.00 -0.03 0.00 0.00 -0.01
Adjusted Net Profit 3.40 2.90 1.77 2.12 2.43 3.38
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 14.78 11.88 10.14 8.02 5.59 2.21
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 18.18 14.78 11.88 10.14 8.02 5.59
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 5.28 4.51 2.70 3.30 3.78 5.24
Earnings Per Share(Adj)-Unit Curr 5.28 4.51 2.70 3.30 3.78 5.24
Book Value 40.01 34.73 30.22 27.52 24.23 20.45
Book Value(Adj)-Unit Curr 40.01 34.73 30.22 27.52 24.23 20.45

Shareholding Pattern

  • Promoter Group

    74.37%

  • Public Share Holding

    25.63%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 4,786,891 74.37 4,786,891 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 4,786,891 74.37 4,786,891 1
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 147,911 2.30 146,411 37
Clearing Members 0 0.00 0 0
Directors of their Relatives 11,801 0.18 11,801 2
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 75,432 1.17 75,282 34
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 52,490 0.82 52,490 68
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 666,315 10.35 666,315 13
Individuals holding nominal share capital up to Rs. 1 lakh 668,567 10.39 643,018 3,404
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 158 0.00 0 1
Others 27,365 0.43 27,365 1
Sub Total 1,650,040 25.63 1,622,683 3,561
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 6,436,931 100.00 6,409,574 3,562

Company Background

Source Natural Foods & Herbal Supplements LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Source Natural Foods & Herbal Supplements Ltd
  • BSE Code : 13792.0
  • ISIN : INE679C01027

  • Incorporation Year

    1995

  • Registered Office

    201 2nd Floor Sumeru Towers
    54/46 39 Jayanagar 4th Block, Bangaluru,
    Karnataka-560041

  • Telephone

    91-80-26087733

  • FAX

    91-80-22449505

  • Chairman

    NARAYANAN NARASIMHAN

  • Managing Director

    Arvind Varchaswi N

  • Company Secretary

    Yash Jain

  • Auditor

    Srinaga & Giridharan/K B Nambiar & Associates

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Venture Capital & Corp. Inv.
    12-10-167 ,
    ,Bharath Nagar
    Mumbai - Hyderbad - 500018

Source Natural Foods & Herbal Supplements Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Source Natural 113.95 70.43 70.38 20.91 17.34
Abbott India 26,684.90 7,217.19 6,929.05 34.31 43.78
Astrazeneca Phar 6,480.05 2,304.07 2,275.58 91.15 27.86
Glaxosmi. Pharma 2,538.95 3,932.76 3,790.20 37.73 58.17
Evonile Pharma 1,814.05 393.10 354.33 -1,119.78 15.94
Cipla 1,410.95 20,102.60 18,979.95 43.00 13.88
Bliss GVS Pharma 620.10 773.53 729.81 40.42 12.51
Amrutanjan Healt 518.10 520.13 502.55 26.14 24.16
Fermenta Biotec. 454.65 474.15 450.25 21.49 18.77
Guj. Themis Bio. 385.75 168.25 165.82 103.14 18.05
Ambalal Sarabhai 35.51 19.52 3.94 60.19 6.77